RT Journal Article
SR Electronic
A1 Parry, Nicola
T1 Favorable Phase 2 Data for Ranolazine in AF
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 9
SP 24
OP 25
DO 10.1177/155989771409014
UL http://mdc.sagepub.com/content/14/9/24.abstract
AB This article presents results of the Ranolazine in Atrial Fibrillation Following an Electrical Cardioversion randomized trial [RAFFAELLO; NCT01534962], an international, double-blind, parallel, Phase 2, dose-ranging study testing three oral ranolazine doses. The results demonstrated safety and provided favorable findings with regard to efficacy for patients with atrial fibrillation.